Salidroside reversed the massive accumulation of β-catenin in the nucleus of ADR nephropathy, decreased the expression of nephrin and podocin, and improved proteinuria, renal fibrosis and podocyte injury in ADR nephropathy (Huang et al., 2019). This evidence concerns the gene NPHS2 and renal fibrosis.